Introduction: The prognostic significance of neutrophil-to-lymphocyte ratio (NLR), derived-neutrophil-to-lymphocyte ratio (d-NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) have been shown in many diseases. To the best of our knowledge, there is no published report evaluation of those parameters in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The aims of this study are to evaluate the parameters in predicting in-hospital mortality in patients with AECOPD.
INTRODUCTION
The World health organization (WHO) in fact sheet number 315 (March 2015) stated that: "Chronic obstructive pulmonary disease (COPD) is a lifethreatening lung disease that interferes with normal breathing. It is more than a "smoker's cough". More than 3 million people died of COPD in 2012, which is equal to 6% of all deaths globally that year. More than 90% of COPD deaths occur in low-and middleincome countries." (1) .
COPD was ranked as the sixth cause of death in 1990, will become the third leading cause of death worldwide by 2020. Acute exacerbations of COPD (AECOPD) are the most common causes of hospitalization and death among COPD patients (2) . Different biochemical markers have been used in AECOPD patients to predict the outcome; however, many of them are time consuming with extra cost.
It has been well recognized that inflammation plays an important role in COPD. Therefore, circulating biomarkers that reflect the status of inflammation can serve as potential predictors for the prognosis of AECOPD patients.
In recent years, peripheral blood neutrophil-tolymphocyte ratio (NLR), derived-neutrophil-tolymphocyte ratio (d-NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) are widely investigated as useful predictors for prognosis in many disease (3) .
NLR is a predictor of mortality in several diseases (4) . Elevated NLR was an independent prognostic factor for chronic kidney disease, diabetes mellitus, coronary artery disease, appendicitis, systemic lupus erythematosus, Sjogren syndrome, and cystic fibrosis (5) (6) (7) (8) (9) (10) (11) (12) . In several other diseases, an elevated NLR has been implicated as the marker of a poorer outcome. In patients with stage 4 chronic kidney disease, those with an NLR > 3 had a worse prognosis and a significantly faster progression to the dialysis (5) .
However, to the best of our knowledge, only one study in COPD patients, by Gunny et al., showed that in AECOP patients NLR was higher than in stable COPD, and in stable COPD higher than in control. They haven't studied the relation to outcome (13) . LMR, d-NLR, and PLR have not been studied in COPD so far.
The aim of this study was to detect a relationship between simple, inexpensive, and easily available NLR, d-NLR-PLR, and LMR parameters with outcome in AECOPD.
MATERIALS and METHODS
This is a retrospective study of patients who were hospitalized with AECOPD in two referral centers in the cities of Tabriz (Imam-Reza hospital) and Urmia (Imam-Khomeini hospital), Iran, from July 2012-2015. Hospital charts were reviewed for admission day CBC parameters (Hematology cell counter Technikon H1, USA). Patients with coexistent hematologic or malignant disorders or those patients with discharge on own consent, were excluded. 
ÖZET

Kronik obstrüktif akciğer hastalığı alevlenme olgularında başvuru nötrofil lenfosit oranı ile prognoz arasındaki ilişki
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Statistical Analysis
We used SPSS 23 IBM software for analysis. We grouped patients with AECOPD to two groups, those who died in hospital and those who discharged hospital alive. We have made comparison of two groups, and p< 0.05 was considered statistically significant. The CBC parameters were entered to SPSS software. Then NLR, PLR, LMR, d-NLR were computed as new variables by SPSS "transform, compute" orders. NLR and PLR were calculated as the ratio of the neutrophils and platelets to lymphocytes, and LMR from lymphocytes to monocytes counts. d-NLR was calculated by dividing the absolute neutrophil count by the difference between leukocytes and neutrophil count [d-NLR= Neutrophil count to (white cell count-neutrophil count)].
Categorical data were described as frequencies and were compared using the chi-square test. To test the normal distribution, we used the Kolmogorov-Smirnov test. Differences in the continuous variables between groups were determined using Student's t-test or the Mann-Whitney U test for variables with or without normal distribution, respectively. Thereafter, we entered variables with significant association with mortality (p< 0.05) in univariate analysis to binary logistic regression analysis, with the "Enter" method. We used receiver-operating characteristic (ROC) curve analysis to identify the best discriminatory cut-off value for NLR, PLR, LMR, and d-NLR.
RESULTS
In total, 315 hospital charts were reviewed, and their demographic characteristics are presented in Table 1 . Of 315 patients, 70 (22.2%) patients died in hospital and 245 (77.8%) left hospital alive. Tables 2 and 3 show univariate analysis and comparison of two groups of AECOPD (death in hospital and discharged alive) for categorical and continuous variables, respectively. NLR, d-NLR, anemia, thrombocytopenia, old age, and male sex had statistically significant association with in-hospital mortality. PLR, monocyte count, and presence of comorbidity were not statistically significant (p> 0.05). We used the binary logistic regression model to evaluate the values of age, sex, NLR, anemia, and thrombocytopenia as independent risk factors for in-hospital mortality. NLR showed the highest odds ratio, both in univariate analysis ( Table 2 , odds= 3.80), and in binary logistic regression analysis (Table 4 , odds= 3.58).
In the ROC curve analysis, the NLR had the highest area under the curve (AUC) value of 0.717 (95% CI, 0.623-0.811) with a cut-off value of 4, and it had a sensitivity of 87%, specificity of 40%. Table 5 and Figure 1 show ROC curve results for NLR, LMR, PLR, neutrophils, and lymphocytes.
DISCUSSION
This study is the first to our knowledge that shows the association of NLR with mortality in patients with AECOPD. NLR was more predictive than neutrophil and lymphocyte counts alone because NLR integrates these two inflammatory markers, indicating opposing clinical outcomes. The suggested mechanisms for association of high NLR with poor outcome in cancers, is that a subpopulation of neutrophils suppresses T-cells activation through the production of reactive oxygen species, nitric oxide, and arginase (14, 15) . Assessment of the NLR gives information about two different immune pathways concomitantly, and is an indicator of the overall inflammatory status of the body. First, neutrophils that are responsible for lasting inflammation and second, the pathway that is related to lymphocytes, which have a regulatory function (16) .
There are no similar studies in AECOPD; however, these findings are consistent with several other studies in other inflammatory diseases. Elevated NLR associated with increased tumor necrosis factor (TNF) alpha, and interleukins of IL-6, IL-7, IL-8, IL-12, and IL-17 (17, 18) . These markers associated with poor outcome in critically ill patients. In patients with acute-on-chronic liver failure the NLR was an independent predictor for three-month mortality (19) . Dirican et al., after studying 116 patients with sarcoidosis, reported that NLR increases with increasing stage of sarcoidosis (20) . In a study by Aktimur et al. NLR value (> 9.9) was a diagnostic marker of acute mesenteric ischemia (21) . Among the CBC components, only NLR was associated with gangrenous appendicitis (9) . It has been suggested that elevated NLR has a better prognostic value than white blood cell count or C-reactive protein in acute appendicitis (22) . In patients with acute atrial fibrillation successfully converted to sinus rhythm with amiodarone, those with high NLR had a higher rate of recurrence in the long-term follow up (23). Deng et al. with studying of 389 patients who had undergone gastrectomy, reported that preoperative NLR and d-NLR are prognostic biomarkers in patients with gastric cancer (24) . The NLR has been used to predict outcomes in non-alcoholic fatty liver cystic fibrosis (12, 25) . NLR predicts long-term mortality in patients with ST-segment elevation myocardial infarction (26) . A high pretreatment or preoperative NLR has been reported as an independent poor prognostic factor in cancers of lung, gastric breast, and colon (24, (27) (28) (29) . Tropan and co-workers showed in multivariate analysis an independent significant association between high NLR and poor outcome in 290 patients with diffuse large B-cell lymphoma (30) .
In our study, there was a relation of mortality with d-NLR. This is expected and may have the same value and mechanism of NLR, there is no rational to calculate D-NLR. Only two studies have showed prognostic importance of d-NLR in colorectal cancer and gastric cancer (3, 24) . To the best of our knowledge, there is no study of d-NLR in non-cancer patients.
In our study, there was no association between PLR and mortality rate in the patients with AECOPD. This can be explained by the fact that both numerator (platelet count) and denominator (lymphocyte count) have changed in the similar direction, that is, decrement of both platelet and lymphocyte are associated with increased inpatient mortality rate. To the best of our knowledge, this is the first study of prognostic significance of PLR on the AECOPD patients. Platelets play an important role in inflammation. Thrombocytopenia is associated with poor outcome in AECOPD and several other diseases (31) (32) (33) (34) (35) . Association of lymphopenia with mortality has already shown in sepsis, in critically ill emergency general surgical patients, and heart failure (36, 37) .
In our study, anemia also was associated with high mortality in AECOPD. Similar findings are reported in other studies (38) .
In univariate analysis, LMR and lymphocyte count, but not monocyte count, showed significant association with mortality rate (p< 0.05); however, in multivariate analysis, LMR showed no association. This discrepancy is due to the higher impact of low lymphocyte count on the calculations, which is not affected significantly by the monocyte count.
Most reported studies about LMR are in malignant diseases, and there are rare studies in non-malignant diseases. Some studies showed association low LMR with tuberculosis (39, 40) . It is expected, monocytes are target cells for mycobacterial growth and lymphocytes are the major effectors for mycobacterial clearance (40) .
The main limitation of our study is its retrospective nature; however, this limitation may be an advantage of a study that has no bias in management and discharge of patients.
CONCLUSION
Our results proved our hypothesis and indicated elevated NLR was a respective independent prognostic biomarker for in-hospital mortality in AECOPD. NLR was found to have a superior prognostic value with the highest sensitivity and specificity and the largest AUC, and the highest odds ratio for mortality in AECOPD. However LMR and PLR failed to show prognostic significance. We suggest the NLR, which is cheap and easily measurable even in the simplest health-care units, is practical to use for the follow-up of AECOPD.
